# Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition

> **NCT01996501** · PHASE1 · COMPLETED · sponsor: **Torrent Pharmaceuticals Limited**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Olanzapine Orally Disintegrating 5mg Tablets

## Key facts

- **NCT ID:** NCT01996501
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2009-01
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01996501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01996501, "Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01996501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*